# WTT Investment

> WTT Investment is a VC fund backing Biotechnology, Therapeutics and Health Care. See 10 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 10
- Last investment: Jan 2026
- Lead investor: 20%
- Last updated: Aug 2026

WTT Investment is a VC fund focused on Biotechnology and Therapeutics. WTT Investment

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 8 | 80% |
| Therapeutics | 4 | 40% |
| Health Care | 3 | 30% |
| Medical | 2 | 20% |
| Artificial Intelligence | 2 | 20% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 30% |
| Series A | 2 | 20% |
| Venture - Series Unknown | 2 | 20% |
| Seed | 1 | 10% |
| Series C | 1 | 10% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 8 | 80% |
| China | 1 | 10% |
| South Korea | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| RadixArk | RadixArk focuses on developing infrastructure for AI inference and training systems. It builds tools to make frontier-level AI more efficient, accessible, and cost-effective. | $100M | Seed | Jan 21, 2026 | https://x.com/radixark |
| NextPoint Therapeutics | NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells. | $42.5M | Series B | Feb 14, 2024 | https://nextpointtx.com/ |
| Remix Therapeutics | Remix Therapeutics is a biotechnology company that develops novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. | $60M | Venture - Series Unknown | Jan 03, 2024 | https://www.remixtx.com/ |
| Teclison | Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs. | $5.9M | Venture - Series Unknown | Feb 14, 2022 | http://teclison.com/ |
| SK biopharmaceuticals | SK biopharmaceuticals aims to become a top tier specialty pharmaceutical company with global new drugs & innovative pipeline in CNS / metabolic disorders and to provide world class specialized pharmaceutical manufacturing services. | $180M | Series A | Nov 26, 2021 | http://skbp.com |
| Ignis Therapeutics | Ignis Therapeutics is a innovative therapies in the field of central nervous system. | $180M | Series A | Nov 11, 2021 |  |
| Allay Therapeutics | Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States. | $60M | Series C | Sep 15, 2021 | https://www.allaytx.com |
| Brain Technologies | Brain™ invented the world’s first AI that learnt to utilize other AI and software for general purposes. The company has recently raised more than $50M from its venture partners. Brain's investors include Laurene Powell Jobs, Goodwater Capital, and Scott Cook. | $50M |  | Jul 28, 2021 | http://brain.ai/ |
| MycoWorks | MycoWorks is engaged in the creation of sustainable design solutions with advanced biomaterials. The company’s proprietary custom-engineered material is sustainable, versatile, and animal-free, and feels and performs like leather. Their first product, Reishi, and the proprietary platform to make it, Fine Mycelium, are a groundbreaking approach tobiomaterials that delivers unparalleled versatility and unmatched performance in strength, durability, and hand feel. The perfect intersection of art and science, Reishi is the only natural material that performs like cowhide leather and is engineered to meet the highest quality standards.MycoWorks was founded by Sophia Wang and Philip Ross in 2013 and is based in Emeryville, California. | $45M | Series B | Oct 13, 2020 | http://www.mycoworks.com |
| Geltor | Biodesigned proteins for beauty, wellness and beyond. | $91.3M | Series B | Jul 27, 2020 | https://www.geltor.com/ |

10 of 10 investments shown.

## Co-investors
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 4 deals together
- [Arboretum Ventures](https://shizune.co/investors/profile/arboretum-ventures) — VC Fund, 2 deals together
- [Goldman Sachs](https://shizune.co/investors/profile/goldman-sachs) — VC Fund, 2 deals together
- [HBM Healthcare Investments](https://shizune.co/investors/profile/hbm-healthcare-investments-ag) — VC Fund, 2 deals together
- [Humboldt Fund](https://shizune.co/investors/profile/humboldt-fund) — VC Fund, 2 deals together
- [KB Investment](https://shizune.co/investors/profile/kbinvest) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Manufacturing Investors in South Korea](https://shizune.co/investors/manufacturing-investors-south-korea)
- [Manufacturing VC Funds in South Korea](https://shizune.co/investors/manufacturing-vc-funds-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)
- [Biotechnology VC Funds in South Korea](https://shizune.co/investors/biotechnology-vc-funds-south-korea)

## FAQ

### What does WTT Investment invest in?

WTT Investment invests primarily in Biotechnology, Therapeutics and Health Care startups, most often at Series B and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did WTT Investment last invest?

The most recent investment recorded for WTT Investment closed in Jan 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co